Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-squamous NSCLC × Docetaxel × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 391 Lung Neoplasms 157 Neoplasms 30 Adenocarcinoma of Lung 25 Neoplasm Metastasis 21 Breast Neoplasms 20 Prostatic Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 15 Small Cell Lung Carcinoma 15 Melanoma 11 Colorectal Neoplasms 10 Urinary Bladder Neoplasms 9 Stomach Neoplasms 9 Carcinoma, Renal Cell 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Recurrence 8 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Head and Neck Neoplasms 8 Esthesioneuroblastoma, Olfactory 7 Carcinoma, Squamous Cell 7 Salivary Gland Neoplasms 6 Esophageal Neoplasms 6 Carcinoma 6 NSCLC 5 Advanced Non-Small Cell Lung Cancer 5 Adenocarcinoma 5 Triple Negative Breast Neoplasms 4 Sarcoma 4 Pleural Effusion, Malignant 4

Interventions

pyrotinib 1 Platinum 1 Injections 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447118 2025-12-19

PYRAMID-1

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed

Non-squamous NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡